Israel Englander Adicet Bio, Inc. Transaction History

Millennium Management LLC

$224 Billion
Q1 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 4,106,170 shares of ACET stock, worth $5.95 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,106,170

Previous 1,321,587 210.7%

Holding current value

$5.95 Million

Previous $2.5 Million 286.42%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.76 - $3.45 $4.9 Million - $9.61 Million	2,784,583 Added 210.7%	4,106,170 $9.65 Million
Q4 2023 Feb 14, 2024	BUY	$1.11 - $1.89 $601,517 - $1.02 Million	541,908 Added 69.5%	1,321,587 $2.5 Million
Q2 2023 Aug 14, 2023	BUY	$2.13 - $7.13 $1.3 Million - $4.34 Million	608,803 Added 356.28%	779,679 $1.89 Million
Q1 2023 May 15, 2023	BUY	$5.52 - $9.23 $521,579 - $872,133	94,489 Added 123.7%	170,876 $984,000
Q4 2022 Feb 14, 2023	BUY	$7.72 - $21.27 $589,707 - $1.62 Million	76,387 New	76,387 $683,000

Q2 2022 Aug 15, 2022	BUY	$10.26 - $20.81 $1.32 Million - $2.68 Million	128,666 New	128,666 $1.88 Million
Q4 2021 Feb 14, 2022	SELL	$7.37 - $17.49 $167,645 - $397,845	-22,747 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.29 - $9.93 $456,685 - $720,967	-72,605 Reduced 76.14%	22,747 $178,000
Q2 2021 Aug 16, 2021	SELL	$9.19 - $15.93 $778,291 - $1.35 Million	-84,689 Reduced 47.04%	95,352 $981,000
Q1 2021 May 17, 2021	BUY	$12.12 - $17.17 $1.91 Million - $2.71 Million	157,963 Added 715.48%	180,041 $2.36 Million
Q4 2020 Feb 16, 2021	BUY	$10.36 - $14.77 $228,728 - $326,092	22,078 New	22,078 $310,000

Others Institutions Holding ACET

# of Institutions

107

Shares Held

69.5M

Call Options Held

13.3K

Put Options Held

24.6K

View Full List

About Adicet Bio, Inc.

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $58M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

More about ACET

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account